# Introduction

Pymaceuticals, Inc. is a new pharmaceutical company that specializes in anti-cancer medications. Recently, it began screening for potential treatments for squamous cell carcinoma (SCC), a commonly occurring form of skin cancer. This is a report partially analyzing their latest clinical study.


# Data Set

249 mice who were identified with SCC tumors received treatment with a range of drug regimens by Pymaceuticals, Inc. Over the course of 45 days, tumor development was observed and measured.

# Purpose

To compare the performance of Pymaceuticalsâ€™ drug of interest, Capomulin, against the other treatment regimens.

